Crucell N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 29 apr 2008 - 09:19

Statutaire naam Crucell N.V.

Titel Crucell Announces STAR® Research License Agreement with Toyobo Gene Analysis Co. LTD.

Bericht Leiden, The Netherlands, 29 April 2008 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced a non-exclusive STAR® research license agreement with Toyobo Gene Analysis Co. LTD. Under the agreement, Toyobo Gene Analysis will evaluate Crucell’s STAR® technology for generating cell lines for the production of recombinant proteins for third-party customers. Financial details of the agreement were not disclosed.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

200804290000000018_Licence agreement Toyobo_Final.pdf (opens in a new window)

Datum laatste update: 01 september 2024